Defender Capital’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-24,000
| Closed | -$1.32M | – | 37 |
|
|
2023
Q4 | $1.32M | Hold |
24,000
| – | – | 0.46% | 16 |
|
|
2023
Q3 | $1.39M | Hold |
24,000
| – | – | 0.5% | 15 |
|
|
2023
Q2 | $1.29M | Hold |
24,000
| – | – | 0.44% | 15 |
|
|
2023
Q1 | $953K | Hold |
24,000
| – | – | 0.33% | 18 |
|
|
2022
Q4 | $966K | Hold |
24,000
| – | – | 0.39% | 15 |
|
|
2022
Q3 | $712K | Hold |
24,000
| – | – | 0.28% | 20 |
|
|
2022
Q2 | $712K | Hold |
24,000
| – | – | 0.28% | 19 |
|
|
2022
Q1 | $675K | Buy |
24,000
+5,000
| +26% | +$141K | 0.23% | 20 |
|
|
2021
Q4 | $876K | Hold |
19,000
| – | – | 0.28% | 19 |
|
|
2021
Q3 | $624K | Hold |
19,000
| – | – | 0.2% | 27 |
|
|
2021
Q2 | $665K | Hold |
19,000
| – | – | 0.22% | 24 |
|
|
2021
Q1 | $687K | Buy |
19,000
+4,000
| +27% | +$145K | 0.25% | 25 |
|
|
2020
Q4 | $436K | Buy |
15,000
+5,000
| +50% | +$145K | 0.19% | 23 |
|
|
2020
Q3 | $282K | Buy |
+10,000
| New | +$282K | 0.14% | 24 |
|